Why are irreversible, nonselective MAOIs generally reserved for treatment-resistant or atypical depression rather than used first-line?
Choose an answer, then check it.
Clinical Pharmacology · Antidepressants
MAO Inhibitors
On this page 6 sections
In 30 seconds
MAO inhibitors (MAOIs) block the enzyme monoamine oxidase, which normally breaks down serotonin, norepinephrine, and dopamine, so these mood-regulating chemicals build up in the brain. They were among the first antidepressants ever developed, but their dangerous interactions with certain foods and other drugs have pushed them to the back of the treatment line — reserved today mainly for depression that hasn't responded to safer options. A separate, MAO-B-selective branch of this drug family is used not for depression but for Parkinson disease. Because the risks are serious (hypertensive crisis, serotonin syndrome), MAOIs demand some of the most intensive patient education in psychiatric pharmacology.
The college version
Mechanism
Monoamine oxidase (MAO) is an enzyme, found mainly in nerve terminals, the liver, and the gut, that degrades monoamine neurotransmitters after they are done signaling. There are two subtypes: MAO-A preferentially breaks down serotonin and norepinephrine, while MAO-B preferentially breaks down dopamine (both can act on each, with overlap). MAOIs inhibit these enzymes, so serotonin, norepinephrine, and dopamine accumulate in the presynaptic terminal and are available in greater quantity for release into the synapse. The older antidepressant MAOIs are irreversible and nonselective — they permanently disable both MAO-A and MAO-B, so the body must synthesize entirely new enzyme molecules before activity returns, which takes roughly two weeks after the drug is stopped.
Irreversible Nonselective MAOIs
Phenelzine, tranylcypromine, and isocarboxazid are the classic oral irreversible, nonselective MAOIs used for depression. Because they raise serotonin, norepinephrine, and dopamine simultaneously, they are effective, but their toxicity profile means they are reserved for treatment-resistant depression and for atypical depression (a presentation marked by mood reactivity, increased appetite and sleep, and rejection sensitivity) that hasn't improved with SSRIs, SNRIs, or tricyclics. A transdermal selegiline patch delivers a nonselective MAOI effect at low doses while bypassing much of the first-pass gut and liver metabolism that drives the food interaction, making the lowest patch dose less restrictive dietarily, though restrictions still apply at higher doses.
MAO-B-Selective Agents in Parkinson Disease
Selegiline (oral) and rasagiline are selective MAO-B inhibitors at their labeled doses. Because dopamine is broken down mainly by MAO-B, selectively blocking this subtype slows dopamine degradation in the brain, supporting the dopamine that remains in Parkinson disease. At these selective doses, the risk of the tyramine reaction is much lower than with nonselective agents, though selectivity can be lost at higher doses.
Tyramine Reaction and Hypertensive Crisis
Tyramine is an amino acid byproduct found in aged, fermented, or improperly stored foods. It normally triggers norepinephrine release, but is safely broken down by gut and liver MAO-A before reaching circulation in large amounts. When MAO-A is inhibited, tyramine escapes degradation, enters circulation, and triggers a surge of norepinephrine release — producing a hypertensive crisis with severe headache, palpitations, neck stiffness, sweating, and potentially stroke. Patients must avoid aged cheeses, cured or processed meats, tap beers and certain wines, fermented soy products, and overripe or spoiled foods, and must be taught to recognize and seek emergency care for a sudden severe headache or other crisis warning signs.
Serotonin Syndrome and Washout Requirements
Combining an MAOI with any other serotonergic drug risks serotonin syndrome (agitation, hyperthermia, tremor, clonus, autonomic instability). Because MAOI enzyme inhibition is irreversible, a mandatory washout period is required both before starting an MAOI after another serotonergic drug and before starting another serotonergic drug after stopping an MAOI. Fluoxetine is the classic teaching example: its long half-life and active metabolite require an extended washout (often cited as around five weeks) before an MAOI may be started, far longer than the washout needed for shorter-acting serotonergic agents.
Other Interactions
MAOIs also interact dangerously with indirect-acting sympathomimetics (found in many decongestants), which release stored norepinephrine and can precipitate hypertensive crisis; with meperidine, which can cause a severe, potentially fatal reaction; and with dextromethorphan, an over-the-counter cough suppressant that can trigger serotonin syndrome.
Orthostatic Hypotension and Patient Teaching
A drop in blood pressure on standing is a common effect of MAOIs, requiring teaching about rising slowly and reporting dizziness. Given the food, drug, and washout complexity, patients need thorough, repeated teaching: a written list of foods and drugs to avoid, instructions to check with a pharmacist before taking any new medication (including over-the-counter products), recognition of crisis symptoms, and the importance of carrying identification noting MAOI use.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine your brain has little cleanup crews (an enzyme called MAO) whose job is to sweep away certain "feel-good" chemical messengers once they've done their job. In depression, sometimes there isn't enough of these messengers hanging around. MAOIs work by telling the cleanup crew to stop sweeping, so more of the good messengers stick around and can be used again. The catch is that this same cleanup crew also handles a substance in certain foods (like old cheese or cured meats), and without the crew on duty, that substance builds up and can cause a dangerous blood pressure spike. That's why people on these medicines have a strict list of foods to avoid and have to be very careful about mixing other medicines in too, since some of those "boost" the same messengers in a way the body can't handle.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient on tranylcypromine calls the clinic reporting a sudden severe headache, sweating, and palpitations after eating at a party. What should the nurse suspect, and what dietary factor likely caused it?
Show answer
Possible hypertensive crisis, likely from eating a tyramine-rich food (such as aged cheese, cured meat, or tap beer).
The nurse should treat this as an emergency and get the patient to care immediately, since these symptoms match a tyramine-triggered blood pressure spike in someone taking a nonselective MAOI.
Explain why selegiline and rasagiline are used differently in clinical practice than phenelzine, even though all three inhibit MAO enzymes.
Show answer
Selegiline and rasagiline are used at doses that selectively spare MAO-A, mainly blocking MAO-B to protect dopamine for Parkinson disease, with a much lower tyramine risk, whereas phenelzine nonselectively blocks both enzymes for depression and carries the full dietary and drug interaction burden.
It's the difference between a scalpel and a broad sweep — one targets just the dopamine cleanup crew, the other shuts down cleanup for all three messengers at once.
Quick check
3 questions here. Answers stay hidden until you check.
Which enzyme subtype is primarily responsible for the tyramine reaction when inhibited?
Choose an answer, then check it.
Why is a long washout period required after stopping fluoxetine before starting an MAOI?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.